E
Eurobio Scientific
Innovating molecular diagnostics to support transplantation, infectious disease and oncology
At a glance
- Status
- Listed
- Founded
- 1997
- Headquarters
- Les Ulis, France
- Listing
- IPO 2005
- Sector
- Biotech & Life Sciences
- Outcome tier
- Thoroughbred$100M+ revenue
Knowledge graph
News
More headlines
Open roles
Eurobio Scientific in the Les Ulis ecosystem
The Eurobio Scientific office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
3 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Eurobio Scientific was the backer or acquirer, 2012–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Eurobio Scientific's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Eurobio Scientific's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Eurobio Scientific on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Eurobio Scientific on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

